WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CVKD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.4M
Current Profit Margin
0%

CVKD Return on Equity

Current Company
-141.2%
Current Industry
-63.5%
Current Market
60.5%
CVKD's Return on Equity (-141.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CVKD announces earnings.

CVKD Return on Assets

Current Company
-129.2%
Current Industry
2.9%
CVKD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CVKD Return on Capital Employed

Current Company
-108.42%
Current Industry
19.5%

CVKD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CVKD$0.00-$8.34M-$8.36MN/AN/A
PSTV$4.91M-$12.18M-$13.32M+10.49%N/A
EFTR$0.00-$32.78M-$35.81M-100.00%N/A
ENVB$0.00-$16.86M-$17.46M-100.00%N/A
KA$5.44M-$13.01M-$14.10M+13.89%N/A
View Top Biotech Stocks

Cadrenal Therapeutics Earnings & Revenue FAQ

What were CVKD's earnings last quarter?

On Invalid Date, Cadrenal Therapeutics (NASDAQ: CVKD) reported Q4 2023 earnings per share (EPS) of -$0.05, up 92.06% year over year. Total Cadrenal Therapeutics earnings for the quarter were -$1.14 million. In the same quarter last year, Cadrenal Therapeutics's earnings per share (EPS) was -$0.63.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.

What was CVKD's earnings growth in the past year?

As of Q2 2024, Cadrenal Therapeutics's earnings has grown year over year. Cadrenal Therapeutics's earnings in the past year totalled -$8.36 million.

What was CVKD's revenue last quarter?

On Invalid Date, Cadrenal Therapeutics (NASDAQ: CVKD) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cadrenal Therapeutics's revenue was $0.00.

What was CVKD's revenue growth in the past year?

As of Q2 2024, Cadrenal Therapeutics's revenue has grown null year over year. Cadrenal Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.